We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$115B
AUM Growth
+$6.24B
Cap. Flow
+$1B
Cap. Flow %
0.87%
Top 10 Hldgs %
23.71%
Holding
4,165
New
247
Increased
1,898
Reduced
1,581
Closed
296

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Healthcare 8.69%
3 Financials 8.53%
4 Industrials 6.69%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JILL icon
3451
J. Jill
JILL
$283M
$217K ﹤0.01%
+8,343
New +$221K
CIVB icon
3452
Civista Bancshares
CIVB
$595M
$216K ﹤0.01%
12,801
-133
-1% -$2.76K
QJUN icon
3453
FT Vest Growth-100 Buffer ETF June
QJUN
$684M
$216K ﹤0.01%
10,582
+100
+1% +$1.91K
SKYW icon
3454
Skywest
SKYW
$4.21B
$215K ﹤0.01%
9,698
-1,431
-13% -$28K
PENG
3455
Penguin Solutions Inc
PENG
$3.12B
$215K ﹤0.01%
12,469
-2,289
-16% -$38.2K
GHYG icon
3456
iShares US & Intl High Yield Corp Bond ETF
GHYG
$199M
$214K ﹤0.01%
+4,986
New +$211K
GRX
3457
Gabelli Healthcare & Wellness Trust
GRX
$147M
$213K ﹤0.01%
21,135
-10,581
-33% -$108K
NEN icon
3458
New England Realty Associates
NEN
$213K ﹤0.01%
3,000
GMAR icon
3459
FT Vest US Equity Moderate Buffer ETF March
GMAR
$397M
$212K ﹤0.01%
+6,993
New +$210K
ALRM icon
3460
Alarm.com
ALRM
$2.74B
$212K ﹤0.01%
4,223
-719
-15% -$37K
GDL
3461
GDL Fund
GDL
$91.9M
$212K ﹤0.01%
27,035
-289
-1% -$2.3K
ARNC
3462
DELISTED
Arconic Corporation
ARNC
$212K ﹤0.01%
8,075
-9,096
-53% -$224K
MDYG icon
3463
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.97B
$210K ﹤0.01%
3,075
-25
-0.8% -$1.71K
DMXF icon
3464
iShares ESG Advanced MSCI EAFE ETF
DMXF
$974M
$210K ﹤0.01%
3,529
-4,853
-58% -$282K
RRBI icon
3465
Red River Bancshares
RRBI
$681M
$210K ﹤0.01%
4,355
MED icon
3466
Medifast
MED
$128M
$209K ﹤0.01%
+2,021
New +$224K
AQNU
3467
DELISTED
Algonquin Power & Utilities Corp Units
AQNU
$209K ﹤0.01%
+7,000
New +$190K
MAT icon
3468
Mattel
MAT
$4.25B
$208K ﹤0.01%
11,324
-251
-2% -$4.66K
VTS icon
3469
Vitesse Energy
VTS
$682M
$208K ﹤0.01%
+10,935
New +$189K
VC icon
3470
Visteon
VC
$2.86B
$207K ﹤0.01%
1,323
-2,768
-68% -$428K
BBD icon
3471
Banco Bradesco
BBD
$34.3B
$207K ﹤0.01%
79,175
-35,884
-31% -$95.4K
KURA icon
3472
Kura Oncology
KURA
$896M
$207K ﹤0.01%
16,961
+1,272
+8% +$15.9K
PMTS icon
3473
CPI Card Group
PMTS
$334M
$207K ﹤0.01%
+4,604
New +$171K
IOT icon
3474
Samsara
IOT
$24B
$207K ﹤0.01%
10,500
-3,700
-26% -$58.7K
MCN
3475
Madison Covered Call & Equity Strategy Fund
MCN
$119M
$207K ﹤0.01%
26,036
+3,684
+16% +$29.2K

Similar funds

Raymond James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Raymond James & Associates held 4,165 positions worth $115B, up 5.7% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2023 filing shows 247 new, 1,898 increased, 1,581 reduced and 296 closed positions. Its largest new stake was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2023 buy was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2023, an estimated $413M increase.
  • Raymond James & Associates's biggest Q1 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $18.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $115B portfolio in Q1 2023.
  • Raymond James & Associates opened 247 new positions and closed 296 in Q1 2023.
  • Raymond James & Associates's portfolio value rose 5.7% quarter-over-quarter to $115B.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.